COSMO PHARMACEUTICALS NV (C43.DE) Earnings History & Surprises

FRA:C43 • NL0011832936

48.8 EUR
-1.2 (-2.4%)
Last: Apr 29, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

Past quarterly earnings results for COSMO PHARMACEUTICALS NV (C43.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateJul 23, 2025

Last Reported

Most Recent
Release DateMar 6, 2025
PeriodQ4 / 2024
EPS Reported
EPS Surprise %
Revenue Surprise 5.78%

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (EUR)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2024 2.71 - 177.08% 130.551M 123.42M 5.78% 165.79%
Q2 2024 4.72 4.35 8.58% 5,028.26% 136.237M 145.86M -6.60% 212.03%
Q4 2023 0.98 - 70.89% 49.119M 69.36M -29.18% -18.92%
Q2 2023 0.09 0.06 50.33% -80.67% 43.661M 45.9M -4.88% 5.18%
Q4 2022 0.57 0.91 -36.88% -29.78% 60.578M 59.16M 2.40% 65.27%
Q2 2022 0.48 -0.06 877.78% 219.00% 41.511M 39.78M 4.35% 46.06%
Q4 2021 0.82 - 342.86% 36.654M 33.66M 8.89% 4.53%
Q2 2021 -0.40 -0.41 1.96% -90.48% 28.42M 29.58M -3.92% 9.80%
Q4 2020 -0.34 -0.71 52.94% - 35.066M 27.405M 27.95% -
Q2 2020 -0.21 -0.20 -2.94% - 25.883M 25.5M 1.50% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

C43.DE EPS Q2Q GrowthC43.DE EPS Q2Q GrowthEPS Q2Q Growth Q2/21 Q4/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 0 1K 2K 3K 4K 5K

Revenue Historical Q2Q growth and Acceleration

C43.DE Revenue Q2Q GrowthC43.DE Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q4/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 0 50 100 150 200

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

Related analysis

C43.DE Overview C43.DE Technical Analysis Report C43.DE Fundamental Analysis Report C43.DE Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

COSMO PHARMACEUTICALS NV / C43.DE Earnings FAQ

What is the most recent earnings date for C43 stock?

COSMO PHARMACEUTICALS NV (C43.DE) last reported earnings on 3/6/2025.


Did C43 stock beat earnings estimates in the most recent quarter?

COSMO PHARMACEUTICALS NV (C43.DE) missed EPS estimates and beat revenue estimates in the most recent quarter.